Business Update
License agreement for platinum-containing, anticancer drug candidates
Published in Cancer Weekly, January 11th, 2005
Under the terms of the agreement, CTI has development and commercialization rights to the compounds. At the same time, Roche has granted CTI a worldwide license for bisplatinum compounds under its patents. Both agreements foresee certain milestone payments and royalties on future sales of the drugs.
"Bisplatinum compounds are part of an important class of anticancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-01-11)
More Articles from Cancer Weekly
- Breast Cancer
Novel enzyme protects breast tumor cells from oxidative stress - Breast Cancer
Study finds radiation therapy may not be needed after breast cancer surgery - Cancer Genetics
PIK3CA is an oncogene in ovarian cancer, common mutation in early breast cancer - Cancer Immunology
Human body makes antibodies that recognize metastatic breast cancer tumors - Prostate Cancer Therapy
Antibody-chemotherapeutic conjugate designed for prostate cancer therapy - Acute Leukemia Therapy
FLAD regimen shows promise for high-risk patients - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
